• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素在ST过滤器中的潴留:一项体外研究

Vancomycin Sequestration in ST Filters: An In Vitro Study.

作者信息

Baud Frédéric J, Houzé Pascal, Raphalen Jean-Herlé, Philippe Pascal, Lamhaut Lionel

机构信息

Département d'Anesthésie et de Réanimation, Adult Intensive Care Unit, Necker Hospital, 75015 Paris, France.

EA7323, Université de Paris, 75006 Paris, France.

出版信息

Antibiotics (Basel). 2023 Mar 21;12(3):620. doi: 10.3390/antibiotics12030620.

DOI:10.3390/antibiotics12030620
PMID:36978488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10045619/
Abstract

BACKGROUND

Sequestration of vancomycin in ST filters used in continuous renal therapy is a pending question. Direct vancomycin-ST interaction was assessed using the in vitro NeckEpur technology.

METHOD

ST150 filter and Prismaflex dialyzer, Baxter-Gambro, were used. Two modes were assessed in duplicate: (i) continuous diafiltration (CDF): 4 L/h, (ii) continuous dialysis (CD): 2.5 L/h post-filtration.

RESULTS

The mean initial vancomycin concentration in the central compartment (CC) was 51.4 +/- 5.0 mg/L. The mean percentage eliminated from the CC over 6 h was 91 +/- 4%. The mean clearances from the CC by CDF and CD were 2.8 and 1.9 L/h, respectively. The mean clearances assessed using cumulative effluents were 4.4 and 2.2 L/h, respectively. The mean percentages of the initial dose eliminated in the effluents from the CC by CDF and CD were 114 and 108% with no detectable sequestration of vancomycin in both modes of elimination.

DISCUSSION

Significant sequestration adds a clearance to that provided by CDF and CD. The study provides multiple evidence from the CC, the filter, and the effluents of the lack of an increase in total clearance in comparison with the flow rates without significant sequestration in the ST filter comparing cumulative effluents to the initial dose in the CC.

CONCLUSIONS

There is no evidence ST filters directly sequestrate vancomycin.

摘要

背景

在连续性肾脏治疗中使用的ST滤器对万古霉素的截留是一个悬而未决的问题。使用体外NeckEpur技术评估了万古霉素与ST的直接相互作用。

方法

使用百特-金宝公司生产的ST150滤器和Prismaflex透析器。以一式两份的方式评估两种模式:(i)连续性透析滤过(CDF):4L/h,(ii)连续性透析(CD):滤过后2.5L/h。

结果

中央腔室(CC)中万古霉素的平均初始浓度为51.4±5.0mg/L。6小时内从CC中清除的平均百分比为91±4%。CDF和CD从CC的平均清除率分别为2.8L/h和1.9L/h。使用累积流出液评估的平均清除率分别为4.4L/h和2.2L/h。CDF和CD从CC流出液中清除的初始剂量的平均百分比分别为114%和108%,在两种清除模式下均未检测到万古霉素的截留。

讨论

显著的截留增加了CDF和CD所提供的清除率。该研究从CC、滤器和流出液中提供了多个证据,表明与ST滤器中无显著截留时的流速相比,总清除率没有增加,将累积流出液与CC中的初始剂量进行比较。

结论

没有证据表明ST滤器直接截留万古霉素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcb9/10045619/d3bcf031d9a9/antibiotics-12-00620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcb9/10045619/e2d953f17b7f/antibiotics-12-00620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcb9/10045619/d3bcf031d9a9/antibiotics-12-00620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcb9/10045619/e2d953f17b7f/antibiotics-12-00620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcb9/10045619/d3bcf031d9a9/antibiotics-12-00620-g002.jpg

相似文献

1
Vancomycin Sequestration in ST Filters: An In Vitro Study.万古霉素在ST过滤器中的潴留:一项体外研究
Antibiotics (Basel). 2023 Mar 21;12(3):620. doi: 10.3390/antibiotics12030620.
2
Elimination of fluconazole during continuous renal replacement therapy. An in vitro assessment.氟康唑在连续肾脏替代治疗中的清除。一项体外评估。
Int J Artif Organs. 2021 Jul;44(7):453-464. doi: 10.1177/0391398820976144. Epub 2020 Nov 21.
3
Elimination of cefotaxime using polysulfone and polyacrylonitrile-derived filters: An assessment.使用聚砜和聚丙烯腈衍生的过滤器消除头孢噻肟:评估。
Int J Artif Organs. 2023 Feb;46(2):113-119. doi: 10.1177/03913988221143803. Epub 2022 Dec 30.
4
Diafiltration flowrate is a determinant of the extent of adsorption of amikacin in renal replacement therapy using the ST150-AN69 filter: An in vitro study.透析液流量是 ST150-AN69 过滤器行肾脏替代治疗时阿米卡星吸附程度的决定因素:一项体外研究。
Int J Artif Organs. 2020 Dec;43(12):758-766. doi: 10.1177/0391398820911928. Epub 2020 May 1.
5
Caspofungin sequestration in a polyacrylonitrile-derived filter: Increasing the dose does not mitigate sequestration.两性霉素 B 衍生物聚丙稀腈滤器中的两性霉素 B 药物隔离:增加剂量并不能减少药物隔离。
Int J Antimicrob Agents. 2023 Dec;62(6):107007. doi: 10.1016/j.ijantimicag.2023.107007. Epub 2023 Oct 13.
6
Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment.在连续肾脏替代治疗中,通过过滤器吸附改变氨基糖苷类药物的药代动力学。体外评估。
Therapie. 2021 Sep-Oct;76(5):415-424. doi: 10.1016/j.therap.2020.10.005. Epub 2020 Oct 29.
7
Elimination of three doses of gentamicin over three consecutive days using a polyacrylonitrile-derived filter: An in vitro assessment.连续 3 天使用丙烯腈衍生的过滤器消除 3 剂庆大霉素:体外评估。
Int J Artif Organs. 2021 Oct;44(10):641-650. doi: 10.1177/03913988211032236. Epub 2021 Aug 4.
8
Continuous renal replacement therapy in the treatment of severe hyperkalemia: An in vitro study.
Int J Artif Organs. 2020 Feb;43(2):87-93. doi: 10.1177/0391398819865748. Epub 2019 Sep 11.
9
Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis.
Nephrol Dial Transplant. 1992;7(8):848-54.
10
Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy.阿哌沙班在体外连续性肾脏替代治疗期间的药代动力学和透析清除率。
BMC Nephrol. 2021 Jan 30;22(1):45. doi: 10.1186/s12882-021-02248-7.

本文引用的文献

1
Membrane adsorption in vancomycin treatment is membrane type dependent in CVVHDF: dose correction is crucial.在连续性静脉-静脉血液透析滤过(CVVHDF)中,万古霉素治疗中的膜吸附取决于膜的类型:剂量校正至关重要。
Crit Care. 2022 Apr 29;26(1):117. doi: 10.1186/s13054-022-03991-5.
2
Elimination of three doses of gentamicin over three consecutive days using a polyacrylonitrile-derived filter: An in vitro assessment.连续 3 天使用丙烯腈衍生的过滤器消除 3 剂庆大霉素:体外评估。
Int J Artif Organs. 2021 Oct;44(10):641-650. doi: 10.1177/03913988211032236. Epub 2021 Aug 4.
3
Carboxyhemoglobin, a reliable diagnosis biomarker for hemolysis in intensive care unit: a retrospective study.
碳氧血红蛋白,重症监护病房溶血的可靠诊断生物标志物:一项回顾性研究。
Crit Care. 2021 Jan 5;25(1):7. doi: 10.1186/s13054-020-03437-w.
4
Elimination of fluconazole during continuous renal replacement therapy. An in vitro assessment.氟康唑在连续肾脏替代治疗中的清除。一项体外评估。
Int J Artif Organs. 2021 Jul;44(7):453-464. doi: 10.1177/0391398820976144. Epub 2020 Nov 21.
5
Alteration of the pharmacokinetics of aminoglycosides by adsorption in a filter during continuous renal replacement therapy. An in vitro assessment.在连续肾脏替代治疗中,通过过滤器吸附改变氨基糖苷类药物的药代动力学。体外评估。
Therapie. 2021 Sep-Oct;76(5):415-424. doi: 10.1016/j.therap.2020.10.005. Epub 2020 Oct 29.
6
Adsorption of vancomycin, gentamycin, ciprofloxacin and tygecycline on the filters in continuous renal replacement therapy circuits: in full blood in vitro study.万古霉素、庆大霉素、环丙沙星和替加环素在连续肾脏替代治疗回路中的过滤器上的吸附:全血体外研究。
J Artif Organs. 2021 Mar;24(1):65-73. doi: 10.1007/s10047-020-01214-8. Epub 2020 Oct 8.
7
Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.持续肾脏替代治疗期间抗菌药物剂量优化的建议。
Front Pharmacol. 2020 May 29;11:786. doi: 10.3389/fphar.2020.00786. eCollection 2020.
8
Should and Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General Principles of Pharmacokinetics?连续性肾脏替代治疗期间抗菌药物的应用及研究是否应遵循药代动力学的一般原则?
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.00388-20.
9
Diafiltration flowrate is a determinant of the extent of adsorption of amikacin in renal replacement therapy using the ST150-AN69 filter: An in vitro study.透析液流量是 ST150-AN69 过滤器行肾脏替代治疗时阿米卡星吸附程度的决定因素:一项体外研究。
Int J Artif Organs. 2020 Dec;43(12):758-766. doi: 10.1177/0391398820911928. Epub 2020 May 1.
10
Comparison of adsorption of selected antibiotics on the filters in continuous renal replacement therapy circuits: in vitro studies.连续肾脏替代治疗回路中选定抗生素在滤器上的吸附比较:体外研究
J Artif Organs. 2020 Jun;23(2):163-170. doi: 10.1007/s10047-019-01139-x. Epub 2019 Oct 20.